(Q51471873)

English

Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA.

scientific article published in January 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Gherardo Mazziotti

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Laura De Marinis

1

object named as

Laura De Marinis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Antonio Bianchi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alessandra Fusco

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Vincenzo Cimino

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Marilda Mormando

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Laura Tilaro

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Alfredo Pontecorvi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Andrea Giustina

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

227-232

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

https://scigraph.springernature.com/pub.10.1007/s11102-007-0037-7

0 references

Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0037-7

21 January 2018

Diagnosis and treatment of acromegaly complications

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0037-7

21 January 2018

Resistance to somatostatin analogs in acromegaly: an evolving concept?

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0037-7

21 January 2018

Evaluation of insulin resistance in acromegalic patients before and after treatment with somatostatin analogues

1 reference

https://api.crossref.org/works/10.1007%2FS11102-007-0037-7

21 January 2018

Consensus statement: medical management of acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular function in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The relative roles of growth hormone and IGF-1 in controlling insulin sensitivity

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pegvisomant: an advance in clinical efficacy in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Standards of medical care in diabetes--2006

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose-dependent effect of octreotide on insulin secretion after OGTT in obesity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the effects of pegvisomant and octreotide on glucose, insulin, gastrin, cholecystokinin, and pancreatic polypeptide responses to oral glucose and a standard mixed meal

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting somatostatin analog therapy of acromegaly: a meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A nationwide survey of mortality in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacologic therapies for acromegaly: a review of their effects on glucose metabolism and insulin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Factors influencing mortality in acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Criteria for cure of acromegaly: a consensus statement

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for acromegaly management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic complications of acromegaly: epidemiology, pathogenesis, and management

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/17484056

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11102-007-0037-7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17484056%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51471873&oldid=1650839243"